Christopher Benecchi
Chief Operating Officer · Sage Therapeutics, Inc.
Individual
- 2024
- Jul 31, 2025
- 2
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Christopher Benecchi's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Michael John Kazley - $45.65M in SDEV purchases and sales in the last 12 months
- Neil Kumar - $45.20M in BBIO purchases and sales in the last 12 months
- RA CAPITAL MANAGEMENT, L.P. - $43.30M in SION purchases and sales in the last 12 months
- Framework Ventures IV L.P. - $42.62M in SDEV purchases and sales in the last 12 months
- Helen Torley - $42.15M in HALO purchases and sales in the last 12 months
- Eric M. Dube - $41.35M in TVTX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Christopher Benecchi?
Christopher Benecchi is a corporate insider, tracked as Chief Operating Officer of Sage Therapeutics, Inc. (SAGE). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Christopher Benecchi last file a Form 4?
The most recent primary Form 4 on record is dated 31 July 2025, one of 2 filings going back to 2024.
